谷氨酰胺轉(zhuǎn)胺酶2(TGM2)cDNA
cDNA of Transglutaminase 2 (TGM2)
tTG; TG2; C Polypeptide,Protein-Glutamine-Gamma-Glutamyltransferase; Transglutaminase 2, Tissue; Transglutaminase C; Transglutaminase H
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
用法
利用無(wú)菌水稀釋到10-100ng/ml.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-20°C不超過(guò)12個(gè)月。
贈(zèng)品
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB830Hu01 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB830Hu01 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB830Hu01 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)多克隆抗體 | WB; IHC; ICC/IF |
| LAB830Hu71 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB830Hu22 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)單克隆抗體 | WB; IHC; ICC; IP. |
| MEB830Hu | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB830Hu | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| HEB830Hu | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB830Hu | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB830Hu | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB830Hu01 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
| CGB830Hu01 | 谷氨酰胺轉(zhuǎn)胺酶2(TGM2)cDNA | PCR、蛋白表達(dá)等 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Connective Tissue Research | Tissue transglutaminase is involved in mechanical load–induced osteogenic differentiation of human ligamentum flavum cells[Pubmed:27115725] |
| American Journal of Respiratory Cell and Molecular Biology | ECM Crosslinking Enhances Fibroblast Growth and Protects Against Matrix Proteolysis in Lung Fibrosis.[pubmed:29053339] |
| 3 Biotech | Metformin attenuates TGF?β1?induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF?β pathways[Pubmed: 32550106] |